14-day Premium Trial Subscription Try For FreeTry Free
$11.65
-0.110 (-0.94%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 DVAX stock ended at $11.65. This is 0.94% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 1.76% from a day low at $11.64 to a day high of $11.85.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
May 11, 2022 $8.10 $8.20 $7.36 $7.45 2 523 667
May 10, 2022 $8.42 $8.66 $8.13 $8.22 2 540 027
May 09, 2022 $8.55 $9.22 $8.12 $8.17 3 575 009
May 06, 2022 $8.44 $9.52 $8.26 $8.94 3 430 422
May 05, 2022 $9.22 $9.24 $8.55 $8.76 2 242 574
May 04, 2022 $9.26 $9.43 $8.60 $9.34 2 015 013
May 03, 2022 $9.28 $9.35 $8.94 $9.15 1 430 389
May 02, 2022 $8.80 $9.32 $8.79 $9.30 2 204 596
Apr 29, 2022 $9.26 $9.40 $8.80 $8.83 1 884 688
Apr 28, 2022 $9.57 $9.68 $8.75 $9.21 2 194 086
Apr 27, 2022 $9.45 $9.70 $9.31 $9.39 1 066 559
Apr 26, 2022 $9.82 $9.96 $9.39 $9.44 1 515 208
Apr 25, 2022 $9.37 $9.98 $9.35 $9.95 1 268 885
Apr 22, 2022 $9.84 $10.19 $9.48 $9.52 555 557
Apr 21, 2022 $10.22 $10.30 $9.76 $9.80 1 406 300
Apr 20, 2022 $10.29 $10.30 $9.94 $10.07 1 148 300
Apr 19, 2022 $10.27 $10.36 $10.08 $10.24 1 027 500
Apr 18, 2022 $10.60 $10.60 $10.16 $10.26 1 274 400
Apr 14, 2022 $10.75 $10.75 $10.39 $10.51 885 334
Apr 13, 2022 $10.14 $10.85 $10.14 $10.67 1 239 633
Apr 12, 2022 $10.49 $10.60 $10.05 $10.13 1 349 836
Apr 11, 2022 $10.41 $10.56 $10.16 $10.25 835 897
Apr 08, 2022 $10.68 $10.85 $10.50 $10.52 1 137 900
Apr 07, 2022 $10.75 $10.90 $10.42 $10.67 1 341 200
Apr 06, 2022 $10.91 $11.08 $10.54 $10.77 1 824 200
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT